secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001683168-25-000583
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNBX Pharmaceuticals enters convertible note with $55K initial, up to $850K, 35% discount conversion
--------------------------------------------------------------------------------

- Issue Date Jan 23, 2025; maturity Oct 30, 2025; 10% interest, 9% OID, default interest 22%.
- Conversion price at 65% of market price (35% discount), exercisable from day 180.
- Company may prepay at 110%-130% of face during first 180 days; later subject to holder agreement.
- Company must register all shares; holder prohibited from short-selling during term.
- Institutional investor 1800 Diagonal Lending LLC provided $55,000, with potential up to $850,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/0001683168-25-000583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316825000583/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer